Free tool
Rare disease stocks
We cover 11 companies grouped under the Rare disease theme. The median market value in the group is $11.98M. Across the group, the median move over the past trading day is +1.75%. Price change over the past year runs from −67.7% to +74.0% across the middle 80 percent of the group, with a median of −31.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
11 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABNX.PA | ABIONYX Pharma SA | $98.59M | Micro cap | −31.34% |
| STX.L | Shield Therapeutics plc | $71.97M | Micro cap | −37.42% |
| ALTHX.PA | THX Pharma Société Anonyme | $71.22M | Micro cap | +73.96% |
| IMM.L | ImmuPharma plc | $31.75M | Micro cap | +89.66% |
| ALDVI.PA | Advicenne S.A. | $30.93M | Micro cap | +39.11% |
| ALBPS.PA | Biophytis S.A. | $11.98M | Micro cap | −50.31% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | $10.27M | Micro cap | −46.03% |
| PHR.WA | Pharmena S.A. | $9.45M | Micro cap | −8.72% |
| BIOSGN.ST | Biosergen AB (publ) | $5.31M | Micro cap | −94.62% |
| APTA.ST | Aptahem AB (publ) | $1.50M | Micro cap | −67.65% |
| ALNEV.PA | Neovacs S.A. | $22.00 | Micro cap | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.